Mauna Kea Technologies (MKEAF, $0.42) was a top loser over the last three months, falling -2 to $0.42 per share. A.I.dvisor analyzed 516 stocks in the Medical Specialties Industry for the 3-month period ending December 28, 2022, and found that of them (4) exhibited an Uptrend while of them (5) demonstrated a Downtrend. 327 similar cases when MKEAF's price dropped within three months. In out of those 327 cases, MKEAF's price went down during the following month. Based on these historical data, the odds of a Downtrend continuation for MKEAF are